DrugPatentWatch Database Preview
Able Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for ABLE, and what generic and branded alternatives to ABLE drugs are available?
ABLE has sixty-two approved drugs.
Summary for Able
| US Patents: | 0 |
| Tradenames: | 27 |
| Ingredients: | 27 |
| NDAs: | 62 |
| Patent Litigation for Able: | See patent lawsuits for Able |
Drugs and US Patents for Able
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Able | NAPROXEN SODIUM | naproxen sodium | TABLET;ORAL | 076544-001 | Aug 22, 2003 | DISCN | No | No | Start Trial | Start Trial | |||||
| Able | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 040546-001 | Apr 30, 2004 | DISCN | No | No | Start Trial | Start Trial | |||||
| Able | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | SUPPOSITORY;RECTAL | 040504-002 | Apr 11, 2003 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
